DOI QR코드

DOI QR Code

Alport 증후군에서 사구체 기저막의 형태학적 변화와 사구체 상피세포의 구조 및 임상지표와의 관계

Relationship of Glomerular Basement Membrane Alterations to Epithelial Cell Structure and Clinical Parameters in Alport Syndrome

  • 엄혜진 (국민건강보험공단 일산병원 소아청소년과) ;
  • 홍성진 (늘푸른 소아청소년과) ;
  • 이재승 (연세대학교 의과대학 소아과학교실) ;
  • 정현주 (연세대학교 의과대학 병리학교실) ;
  • 김영기 (미네소타대학교 의과대학 소아과학교실) ;
  • 김기혁 (국민건강보험공단 일산병원 소아청소년과)
  • 투고 : 2010.03.16
  • 심사 : 2010.03.31
  • 발행 : 2010.04.30

초록

목 적 : Alport증후군 환자의 사구체 기저막의 형태학적 변화 및 사구체 상피세포의 구조 변화에 따른 임상지표간의 상관 관계를 알아보고자 하였다. 방 법 : Alport 증후군으로 확진된 15명의 환자를 대상으로 하였다. 사구체 기저막을 형태학적 변화에 따라 1) 정상(C1), 2) minor alteration: widening of lamina rara interna or externa without lamina densa changes (C2), 3)nonspecific splitting of lamina densa (C3), 4) basket-weave pattern of lamina densa splitting (C4)의 4가지 범주로 나누고 각 범주에 해당하는 사구체 기저막의 비율을(%) 측정하였다. 또한 각 범주의 사구체 기저막에서 사구체 기저막 $10\;{\mu}m$에 대한 상피세포의 세과여극(slit pore)의 밀도를 구하였고, 나이에 따른 사구체 기저막의 형태학적 변화를 살펴보았다. 결 과 : 요 중 단백질 배설량과 정상 기저막 소견(C1) 사이는 역비례 관계를 보였고(P<0.05), 요 중 단백질 배설량과 비정상 사구체 기저막 소견(C2+C3+C4) 사이는 정비례 관계를 보였다(P<0.05). 비정상적 기저막 소견을 보이는 각 범주와 단백뇨나 크레아티닌 청소율과는 의미 있는 상관관계가 없었다. 크레아티닌 청소율과 정상 사구체 기저막(C1)의 비율과의 관계는 통계적인 의미가 없었고(P=0.085), 비정상 사구체 기저막(C2+C3+C4)의 비율과도 통계적으로 의미가 없었다(P=0.080). 신생검 당시의 나이와 사구체 기저막의 형태학적 변화도 상관관계가 없었다. 결 론 : Alport 증후군 환자에서 사구체 기저막의 변화는 단백뇨와 관련성이 있지만 사구체 상피세포 구조와 사구체여과율과는 관련성이 없었다.

Purpose : This study was performed to evaluate the relationship between glomerular basement membrane (GBM) alterations to epithelial cell (EpC) structure and renal function in Alport Syndrome (AS) patients. Methods : Fifteen patients diagnosed with AS (4-26yrs) were examined. The GBM in AS was categorized as : C1) normal, C2) minor alterations (widening of lamina rara interna or externa without lamina densa change), C3) nonspecific splitting of lamina densa, C4) basket-weaving pattern of lamina densa splitting. The length of each GBM portion along the epithelial side was measured on the systematically obtained electron microscopic photographs. Furthermore to obtain an objective assessment of the degree of glomerular EpC foot process change, the number of slit pores along $10\;{\mu}m$ of peripheral GBM in each category was obtained. Results : The percentage of normal GBM portion (C1) correlated inversely with daily protein excretion (g/day/$m^2$, P<0.05) and sum of the percentage of abnormal GBM portion (C2+C3+C4) had direct correlation with daily protein excretion (g/day/$m^2$, P<0.05). There were no significant relationships between the percentages of other categories of GBM alterations and creatinine clearance or protein excretion. There were no significant relationships between of creatinine clearance in relation to normal GBM(C1) portion as well as that in relation to sum of the percentage of abnormal GBM portion (C2+C3+C4). GBM abnormality did not correlate with age at biopsy. Conclusion : The extent of GBM structural abnormality is related to proteinuria in AS but the epithelial response is uniform even though the GBM ultrastructural lesions are not.

키워드

참고문헌

  1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome and Type IV Collagen. N Engl J Med 2003;348:2543-56. https://doi.org/10.1056/NEJMra022296
  2. Hass M. Alport syndrome and thin glomerular basement membrane nephropathy. Arch Pathol Lab Med 2009;133:224-32.
  3. Harvey SJ, Zheng K, Sado Y, Naito I, Ninomiya Y, Jacobs RM et al. Role of distinct type IV collagen networks in glomerular development and function. Kidney International 1998;54:1857-66. https://doi.org/10.1046/j.1523-1755.1998.00188.x
  4. Zheng K, Perry J, Harvey SJ, Sado Y, Ninomiya Y, Jefferson B et al. Regulation of collaeng type IV genes is organ-specific: Evidence from a canine model of Alport syndrome. Kidney International 2005;68:2121-30.
  5. Heidet L, Cai Y, Guicharnaud L, Antignac C, Gubler M. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am J Pathol 2000; 156:1901-10. https://doi.org/10.1016/S0002-9440(10)65063-8
  6. U.S. Department of Health and Human Services. The 1980 report of the joint national committee on detection, evaluation and treatment of high blood pressure. Washington. DC: NIH Publication 1980:No. 81-1088.
  7. Report of task force on blood pressure control in children. Pediatrics 1977;59(Suppl): 797-820.
  8. Kim KH. Analyzing glomerular disease by stereology. Korean J Pediatr 1996;39:753-61.
  9. Mayhew TM. Basic stereological relationships for quantitative microscopic anatomy simple systematic approach J Anat 1979; 129:95-105.
  10. Kashtan CE, Micheal AF. Alport syndrome. Kidney Int 1996; 50:1445-63. https://doi.org/10.1038/ki.1996.459
  11. Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998;9:1736-50.
  12. Kashtan CE. Familial hematurias: what we know and what we don't. Pediatr Nephrol 2005;20:1027-35. https://doi.org/10.1007/s00467-005-1859-z
  13. Barsotti P, Muda AO, Mazzucco G, Massella L, Basolo B, Maechi MD et al. Distribution of chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome. Nephrol Dial Transplant 2001;16:945-52. https://doi.org/10.1093/ndt/16.5.945
  14. Hinglais N, Grunfield J-P, Bois LE. Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport syndrome). Lab Invest 1972;27:473-87.
  15. Churg J, Sherman RL. Pathologic characteristics of hereditary nephritis. Arch Pathol 1973;95:374-9.
  16. Bethard GA. Grangolm NA. Development of the characteristic ultrastructural lesion of hereditary nephritis during the course of the disease. Am J Med 1977;62:751-6. https://doi.org/10.1016/0002-9343(77)90878-6
  17. Sherman RL, Churg J, Yudis M. Hereditary nephritis with a characteristic renal lesion. Am J Med 1974;56:44-50. https://doi.org/10.1016/0002-9343(74)90749-9
  18. Rumpelt H-J. Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alteration. Clin Nephrol 1980;13:203-7.
  19. Kim KH, Kim Y, Gubler MC, Steffes MW, Lane PH, Kashtan CE et al. Structural-functional relationships in Alport syndrome. J Am Soc Nephrol 1995;5:1659-88.
  20. Gaboardi F, Edefonti A, Imabsciati E, Tarantino A, Mihatsch MJ, Zollinger HU. Alport syndrome (progressive hereditary nephritis). Clin Nephol 1974;2:143-1564.
  21. White RHR, Raafat F, Milford DV, Komianou F, Moghal NE. The Alport nephropathy: clinicopathological correlations. Pediatr Nephrol 2005;20:897-903. https://doi.org/10.1007/s00467-005-1955-0